ASLAN Pharmaceuticals Ltd. EPS - Earnings per Share 2018-2024 | ASLN
ASLAN Pharmaceuticals Ltd. eps - earnings per share from 2018 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| ASLAN Pharmaceuticals Ltd. Annual EPS |
| 2023 |
$-21.52 |
| 2022 |
$-29.44 |
| 2021 |
$-19.20 |
| 2020 |
$-16.00 |
| 2019 |
$-58.00 |
| 2018 |
$-56.00 |
| 2017 |
$-64.00 |
| 2016 |
$-18.00 |
| ASLAN Pharmaceuticals Ltd. Quarterly EPS |
| 2024-03-31 |
$-4.24 |
| 2023-12-31 |
$-5.84 |
| 2023-09-30 |
$-4.48 |
| 2023-06-30 |
$-0.88 |
| 2023-03-31 |
$-10.32 |
| 2022-12-31 |
$-8.32 |
| 2022-09-30 |
$-6.24 |
| 2022-06-30 |
$-7.44 |
| 2022-03-31 |
$-7.44 |
| 2021-12-31 |
$-1.20 |
| 2021-09-30 |
$-4.80 |
| 2021-06-30 |
$-8.00 |
| 2021-03-31 |
$-5.20 |
| 2020-12-31 |
$-4.80 |
| 2020-09-30 |
$-4.00 |
| 2020-06-30 |
$-4.00 |
| 2020-03-31 |
$-3.20 |
| 2019-12-31 |
$-36.00 |
| 2019-09-30 |
$-6.00 |
| 2019-06-30 |
$-10.00 |
| 2019-03-31 |
$-6.00 |
| 2018-12-31 |
$-13.74 |
| 2018-09-30 |
$-13.88 |
| 2018-06-30 |
$-14.98 |
| 2018-03-31 |
$-13.40 |
| 2017-12-31 |
$-22.56 |
| 2017-09-30 |
$-12.24 |
| 2017-06-30 |
$-15.22 |
| 2017-03-31 |
$-13.98 |
